Hikma Pharmaceuticals PLC Net Income for the year ending December 31, 2024: USD 359.00 M

Hikma Pharmaceuticals PLC Net Income is USD 359.00 M for the year ending December 31, 2024, a 88.95% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Hikma Pharmaceuticals PLC Net Income for the year ending December 31, 2023 was USD 190.00 M, a 1.06% change year over year.
  • Hikma Pharmaceuticals PLC Net Income for the year ending December 31, 2022 was USD 188.00 M, a -55.34% change year over year.
  • Hikma Pharmaceuticals PLC Net Income for the year ending December 31, 2021 was USD 421.00 M, a -2.32% change year over year.
  • Hikma Pharmaceuticals PLC Net Income for the year ending December 31, 2020 was USD 431.00 M, a -11.32% change year over year.
Key Data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Selling, General, and Administrative Expenses (SG&A)